Preclinical research, radiation therapy could cause the immune system to attack tumor cells, release tumor neoantigens, activate antitumor T cells, cause tumor-infiltrating T cells to aggregate, and upregulate PD-L1 expression in tumor tissues (32, 33). Here, CD274 is linked to neoplasm.